Firefighters got to the scene near 108th and Nicholas streets, in the West Omaha area, just before 4 a.m. Google is expected to foot the $10,000,000 bill for a dedicated underground pipeline to ...

Champions of artificial intelligence say the technology is poised to take over some of the most traditional titles in finance: stockbroker, portfolio manager, financial adviser. Now, it is coming for ...

The start-up said it would discontinue Sora just three months after signing a multiyear deal to bring Disney characters to the service. By Cade Metz Reporting from San Francisco OpenAI is shutting ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Suno co-founder and CEO Mikey Shulman shared on LinkedIn that the AI music generator has amassed 2 million paid subscribers and $300 million in annual recurring revenue. Just three months ago, Suno ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

CLOQUET, Minn. — The Cloquet Police Department will begin using AI software to draft police reports using body camera footage and audio. While city officials are hopeful the software will streamline ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...